Leading Paediatric Infectious Diseases—Current Trends, Gaps, and Future Prospects in Oral Pharmacotherapeutic Interventions

The global burden of group A streptococcal diseases

Carapetis, J. R., Steer, A. C., Mulholland, E. K., & Weber, M. (2005) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(05)70267-x · Cited by 3,001 · see citing works

Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report

Malfertheiner, P., Mégraud, F., O'Morain, C. A., Gisbert, J. P., Kuipers, E. J., Axon, A. T. R., Bazzoli, F., Gasbarrini, A., Atherton, J. C., Graham, D. Y., et al. (2016) · Gut · doi:10.1136/gutjnl-2016-312288 · Cited by 2,969 · see citing works

Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis

Nair, H., Nokes, D. J., Gessner, B. D., Dherani, M., Madhi, S. A., Singleton, R. J., O'Brien, K. L., Roca, A., Wright, P. F., Bruce, N., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60206-1 · Cited by 2,773 · see citing works

Pathogenesis of Group A Streptococcal Infections

Cunningham, M. W. (2000) · Clinical Microbiology Reviews · doi:10.1128/cmr.13.3.470-511.2000 · Cited by 2,247 · see citing works

Controlled Drug Delivery Systems: Current Status and Future Directions

Adepu, S., & Ramakrishna, S. (2021) · Molecules · doi:10.3390/molecules26195905 · Cited by 1,749 · see citing works

Oral drug delivery with polymeric nanoparticles: The gastrointestinal mucus barriers

Ensign, L. M., Cone, R. A., & Hanes, J. S. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.12.009 · Cited by 1,646 · see citing works

Helicobacter pylori and Gastric Cancer: Factors That Modulate Disease Risk

Wroblewski, L. E., Peek, R. M., & Wilson, K. T. (2010) · Clinical Microbiology Reviews · doi:10.1128/cmr.00011-10 · Cited by 1,455 · see citing works

Clinical Practice Guideline for the Diagnosis and Management of Group A Streptococcal Pharyngitis: 2012 Update by the Infectious Diseases Society of America

Shulman, S. T., Bisno, A. L., Clegg, H. W., Gerber, M. A., Kaplan, E. L., Lee, G. M., Martin, J. M., & Beneden, C. V. (2012) · Clinical Infectious Diseases · doi:10.1093/cid/cis629 · Cited by 1,094 · see citing works

Challenges and Recent Progress in Oral Drug Delivery Systems for Biopharmaceuticals

Homayun, B., Lin, X., & Choi, H. (2019) · Pharmaceutics · doi:10.3390/pharmaceutics11030129 · Cited by 919 · see citing works

Disease Manifestations and Pathogenic Mechanisms of Group A Streptococcus

Walker, M. J., Barnett, T. C., McArthur, J. D., Cole, J. N., Gillen, C. M., Henningham, A., Sriprakash, K. S., Sanderson-Smith, M. L., & Nizet, V. (2014) · Clinical Microbiology Reviews · doi:10.1128/cmr.00101-13 · Cited by 908 · see citing works

Advances in Oral Drug Delivery

Alqahtani, M. S., Kazi, M., Alsenaidy, M. A., & Ahmad, M. Z. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.618411 · Cited by 886 · see citing works

Transmission of H7N7 avian influenza A virus to human beings during a large outbreak in commercial poultry farms in the Netherlands

Koopmans, M., Wilbrink, B., Conyn, M., Natrop, G., van der Nat, H., Vennema, H., Meijer, A., van Steenbergen, J., Fouchier, R. A. M., Osterhaus, A. D. M. E., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15589-x · Cited by 829 · see citing works

Role of nanoparticle size, shape and surface chemistry in oral drug delivery

Banerjee, A., Qi, J., Gogoi, R., Wong, J., & Mitragotri, S. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2016.07.051 · Cited by 777 · see citing works

INTESTINAL FLORA IN NEW-BORN INFANTS

Hall, I. C. (1935) · American journal of diseases of children · doi:10.1001/archpedi.1935.01970020105010 · Cited by 766 · see citing works

Mucoadhesive drug delivery systems

Donnelly, R. F., Shaikh, R., Singh, T. R. R., Garland, M. J., & Woolfson, A. D. (2011) · Journal of Pharmacy And Bioallied Sciences · doi:10.4103/0975-7406.76478 · Cited by 743 · see citing works

Active Targeting Strategies Using Biological Ligands for Nanoparticle Drug Delivery Systems

Yoo, J., Park, C., Yi, G., Lee, D., & Koo, H. (2019) · Cancers · doi:10.3390/cancers11050640 · Cited by 730 · see citing works

Advances in oral transmucosal drug delivery

Patel, V. F., Liu, F., & Brown, M. B. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2011.01.027 · Cited by 579 · see citing works

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults

Gandhi, R. T., Bedimo, R., Hoy, J., Landovitz, R. J., Smith, D. M., Eaton, E., Lehmann, C., Springer, S. A., Sax, P. E., Thompson, M., et al. (2022) · JAMA · doi:10.1001/jama.2022.22246 · Cited by 577 · see citing works

Treatment of Giardiasis

Gardner, T. B., & Hill, D. R. (2001) · Clinical Microbiology Reviews · doi:10.1128/cmr.14.1.114-128.2001 · Cited by 565 · see citing works

Physicochemical properties of mucus and their impact on transmucosal drug delivery

Leal, J., Smyth, H. D. C., & Ghosh, D. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.09.018 · Cited by 560 · see citing works

Diagnosis and Treatment of Extrapulmonary Tuberculosis

Lee, J. Y. (2015) · Tuberculosis & respiratory diseases · doi:10.4046/trd.2015.78.2.47 · Cited by 541 · see citing works

Vancomycin, Metronidazole, or Tolevamer for Clostridium difficile Infection: Results From Two Multinational, Randomized, Controlled Trials

Johnson, S., Louie, T., Gerding, D. N., Cornely, O. A., Chasan-Taber, S., Fitts, D., Gelone, S. P., Broom, C., Davidson, D. M., & for the Polymer Alternative for CDI Treatment (PACT) investigators (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu313 · Cited by 523 · see citing works

Nanotechnology approaches for global infectious diseases

Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520 · see citing works

Antibiotic Prescribing in Ambulatory Pediatrics in the United States

Hersh, A. L., Shapiro, D. J., Pavia, A. T., & Shah, S. S. (2011) · PEDIATRICS · doi:10.1542/peds.2011-1337 · Cited by 510 · see citing works

Nanoparticles: Taking a Unique Position in Medicine

Joseph, T. M., Mahapatra, D. K., Esmaeili, A., Piszczyk, Ł., Hasanin, M. S., Kattali, M., Haponiuk, J. T., & Thomas, S. (2023) · Nanomaterials · doi:10.3390/nano13030574 · Cited by 502 · see citing works

Helicobacter pylori Infection

Crowe, S. E. (2019) · New England Journal of Medicine · doi:10.1056/nejmcp1710945 · Cited by 475 · see citing works

Joint ESPGHAN/NASPGHAN Guidelines for the Management of Helicobacter pylori in Children and Adolescents (Update 2016)

Jones, N. L., Koletzko, S., Goodman, K. J., Bontems, P., Cadranel, S., Casswall, T., Czinn, S., Gold, B. D., Guarner, J., Elitsur, Y., et al. (2017) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001594 · Cited by 467 · see citing works

Pertussis of adults and infants

von Koenig, C. H. W., Halperin, S. A., Riffelmann, M., & Guiso, N. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00452-8 · Cited by 454 · see citing works

The hidden burden of influenza: A review of the extra‐pulmonary complications of influenza infection

Sellers, S. A., Hagan, R. S., Hayden, F. G., & Fischer, W. A. (2017) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12470 · Cited by 438 · see citing works

Extra-intestinal and long term consequences of Giardia duodenalis infections

Halliez, M. C. M. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i47.8974 · Cited by 406 · see citing works

Hunter's Tropical Medicine and Emerging Infectious Diseases

(2020) · Elsevier eBooks · doi:10.1016/c2016-0-01879-x · Cited by 394 · see citing works

Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trial

Chintu, C., Bhat, G. K., Walker, A. S., Mulenga, V., Sinyinza, F., Lishimpi, K., Farrelly, L., Joffe, N., Zumla, A. I., Gillespie, S. H., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17442-4 · Cited by 386 · see citing works

Impact of gastrointestinal tract variability on oral drug absorption and pharmacokinetics: An UNGAP review

Vinarov, Z., Abdallah, M., Agúndez, J. A. G., Allegaert, K., Basit, A. W., Braeckmans, M., Ceulemans, J., Corsetti, M., Griffin, B. T., Grimm, M. F., et al. (2021) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2021.105812 · Cited by 380 · see citing works

Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention

Harris, A. M., Hicks, L. A., & Qaseem, A. (2016) · Annals of Internal Medicine · doi:10.7326/m15-1840 · Cited by 373 · see citing works

Channelled tablets: An innovative approach to accelerating drug release from 3D printed tablets

Sadia, M., Arafat, B. T., Ahmed, W., Forbes, R. T., & Alhnan, M. A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.11.022 · Cited by 369 · see citing works

The role of nanotechnology in the treatment of viral infections

Singh, L., Kruger, H. G., Maguire, G. E. M., Govender, T., & Parboosing, R. (2017) · Therapeutic Advances in Infectious Disease · doi:10.1177/2049936117713593 · Cited by 364 · see citing works

Orally disintegrating films: A modern expansion in drug delivery system

Irfan, M., Rabel, S., Bukhtar, Q., Qadir, M. I., Jabeen, F., & Khan, R. A. (2015) · Saudi Pharmaceutical Journal · doi:10.1016/j.jsps.2015.02.024 · Cited by 362 · see citing works

Guideline for the management of acute sore throat

Pelucchi, C., Grigoryan, L., Galeone, C., Esposito, S., Huovinen, P., Little, P. S., & Verheij, T. J. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03766.x · Cited by 347 · see citing works

Development of Pharmaceutical Nanomedicines: From the Bench to the Market

Halwani, A. A. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14010106 · Cited by 337 · see citing works

Oral delivery of macromolecular drugs: Where we are after almost 100 years of attempts

Moroz, E., Matoori, S., & Leroux, J. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2016.01.010 · Cited by 336 · see citing works

Current status and prospects of HIV treatment

Cihlář, T., & Fordyce, M. W. (2016) · Current Opinion in Virology · doi:10.1016/j.coviro.2016.03.004 · Cited by 336 · see citing works

Pediatric Drug Formulations: A Review of Challenges and Progress

Ivanovska, V., Rademaker, C. M. A., van Dijk, L., & Mantel-Teeuwisse, A. K. (2014) · PEDIATRICS · doi:10.1542/peds.2013-3225 · Cited by 328 · see citing works

Infectious disease and economics: The case for considering multi-sectoral impacts

Smith, K. M., Machalaba, C. C., Seifman, R., Feferholtz, Y., & Karesh, W. B. (2019) · One Health · doi:10.1016/j.onehlt.2018.100080 · Cited by 298 · see citing works

Inorganic nanoparticles in clinical trials and translations

Huang, H., Feng, W., Chen, Y., & Shi, J. (2020) · Nano Today · doi:10.1016/j.nantod.2020.100972 · Cited by 285 · see citing works

Orally Disintegrating Tablets: A Review

Hirani, J. J., Rathod, D., & Vadalia, K. (2009) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v8i2.44525 · Cited by 275 · see citing works

Formulation approaches to pediatric oral drug delivery: benefits and limitations of current platforms

Lopez, F. L., Ernest, T. B., Tuleu, C., & Orlu, M. (2015) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.1060218 · Cited by 266 · see citing works

Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences

Nasser, W., Beres, S. B., Olsen, R. J., Dean, M. A., Rice, K. A., Long, S. W., Kristinsson, K. G., Gottfreðsson, M., Vuopio, J., Räisänen, K., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1403138111 · Cited by 255 · see citing works

Intestinal Absorption Study: Challenges and Absorption Enhancement Strategies in Improving Oral Drug Delivery

Azman, M., Sabri, A. H. B., Anjani, Q. K., Mustaffa, M. F., & Hamid, K. A. (2022) · Pharmaceuticals · doi:10.3390/ph15080975 · Cited by 255 · see citing works

Drug resistant Tuberculosis: A review

Khawbung, J. L., Nath, D., & Chakraborty, S. (2020) · Comparative Immunology Microbiology and Infectious Diseases · doi:10.1016/j.cimid.2020.101574 · Cited by 252 · see citing works

Recommended Antimicrobial Agents for Treatment and Postexposure Prophylaxis of Pertussis: 2005 CDC Guidelines

Tiwari, T., Murphy, T. V., & Moran, J. S. (2005) · PsycEXTRA Dataset · doi:10.1037/e548702006-001 · Cited by 251 · see citing works

Drug repurposing screens and synergistic drug‐combinations for infectious diseases

Zheng, W., Sun, W., & Simeonov, A. M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13895 · Cited by 248 · see citing works

Nanomedicine-based commercial formulations: current developments and future prospects

Thapa, R. K., & Kim, J. O. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00607-6 · Cited by 235 · see citing works

Gastro-retentive drug delivery systems and their in vivo success: A recent update

Mandal, U. K., Chatterjee, B., & Senjoti, F. G. (2016) · Asian Journal of Pharmaceutical Sciences · doi:10.1016/j.ajps.2016.04.007 · Cited by 227 · see citing works

Shorter Treatment for Nonsevere Tuberculosis in African and Indian Children

Turkova, A., Wills, G. H., Wobudeya, E., Chabala, C., Palmer, M., Kinikar, A., Hissar, S., Choo, L., Musoke, P., Mulenga, V., et al. (2022) · New England Journal of Medicine · doi:10.1056/nejmoa2104535 · Cited by 223 · see citing works

Application of chitosan/alginate nanoparticle in oral drug delivery systems: prospects and challenges

Li, S., Zhang, H., Chen, K., Jin, M., Vu, S. H., Jung, S., He, N., Zhou, Z. G., & Lee, M. (2022) · Drug Delivery · doi:10.1080/10717544.2022.2058646 · Cited by 221 · see citing works

Molecular Mechanisms of HIV Entry

Wilen, C. B., Tilton, J. C., & Doms, R. W. (2011) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-0980-9_10 · Cited by 215 · see citing works

Direct healthcare costs of selected diseases primarily or partially transmitted by water

Collier, S. A., Stockman, L., Hicks, L. A., Garrison, L. E., ZHOU, F. J., & Beach, M. J. (2012) · Epidemiology and Infection · doi:10.1017/s0950268811002858 · Cited by 211 · see citing works

Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing

Genina, N., Boetker, J. P., Colombo, S., Harmankaya, N., Rantanen, J., & Bohr, A. (2017) · Journal of Controlled Release · doi:10.1016/j.jconrel.2017.10.003 · Cited by 204 · see citing works

The global prevalence of and factors associated with Helicobacter pylori infection in children: a systematic review and meta-analysis

Yuan, C., Adeloye, D., Luk, T. T., Huang, L., He, Y., Xu, Y., Ye, X., Yi, Q., Song, P., & Rudan, I. (2022) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(21)00400-4 · Cited by 199 · see citing works

Giardiasis surveillance - United States, 2006-2008.

Yoder, J. S., Harral, C., & Beach, M. J. (2010) · PubMed · Cited by 191 · see citing works

Giardia duodenalis in humans and animals – Transmission and disease

Dixon, B. R. (2020) · Research in Veterinary Science · doi:10.1016/j.rvsc.2020.09.034 · Cited by 188 · see citing works

Lipid Based Vesicular Drug Delivery Systems

Jain, S., Jain, V., & Mahajan, S. C. (2014) · Advances in Pharmaceutics · doi:10.1155/2014/574673 · Cited by 183 · see citing works

Efficacy and Safety of Oseltamivir in Children: Systematic Review and Individual Patient Data Meta-analysis of Randomized Controlled Trials

Malosh, R. E., Martin, E. T., Heikkinen, T., Brooks, W. A., Whitley, R. J., & Monto, A. S. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix1040 · Cited by 178 · see citing works

Extrapulmonary Tuberculosis—An Update on the Diagnosis, Treatment and Drug Resistance

Gopalaswamy, R., Dusthackeer, A., Kannayan, S., & Subbian, S. (2021) · Journal of Respiration · doi:10.3390/jor1020015 · Cited by 173 · see citing works

Giardiasis: a pharmacotherapy review

Escobedo, A. A., & Cimerman, S. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.12.1885 · Cited by 173 · see citing works

Medicinal Plants Used in the Treatment of Human Immunodeficiency Virus

Salehi, B., Kumar, N. V. A., Şener, B., Sharifi‐Rad, M., Kılıç, M., Mahady, G. B., Vlaisavljević, S., Iriti, M., Kobarfard, F., Setzer, W. N., et al. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19051459 · Cited by 167 · see citing works

Printed Drug-Delivery Systems for Improved Patient Treatment

Sandler, N., & Preis, M. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.10.002 · Cited by 165 · see citing works

The Psychology of Pandemics

Taylor, S. (2022) · Annual Review of Clinical Psychology · doi:10.1146/annurev-clinpsy-072720-020131 · Cited by 164 · cited 1× · see citing works

Nanovesicular carriers as alternative drug delivery systems: ethosomes in focus

Mbah, C. C., Builders, P. F., & Attama, A. A. (2013) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2013.860130 · Cited by 163 · see citing works

Drug resistant TB – latest developments in epidemiology, diagnostics and management

Tiberi, S., Utjesanovic, N., Galvin, J., Centis, R., D’Ambrosio, L., van den Boom, M., Zumla, A. I., & Migliori, G. B. (2022) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2022.03.026 · Cited by 161 · see citing works

National, regional, and global causes of mortality in 5–19-year-olds from 2000 to 2019: a systematic analysis

Liu, L., Villavicencio, F., Yeung, D., Perin, J., Lopez, G., Strong, K. L., & Black, R. E. (2022) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00566-0 · Cited by 157 · see citing works

Diagnosis and treatment of streptococcal pharyngitis

Fink, H. W. (1985) · JAMA · doi:10.1001/jama.254.7.907 · Cited by 157 · see citing works

Current challenges and future perspectives in oral absorption research: An opinion of the UNGAP network

Vinarov, Z., Abrahamsson, B., Artursson, P., Batchelor, H. K., Berben, P., Bernkop‐Schnürch, A., Butler, J., Ceulemans, J., Davies, N. M., Dupont, D., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.02.001 · Cited by 155 · see citing works

Antiviral Drugs in Influenza

Świerczyńska, M., Mirowska-Guzel, D. M., & Pindelska, E. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19053018 · Cited by 142 · see citing works

The Treatment of Tuberculosis

Peloquin, C. A., & Davies, G. (2021) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.2261 · Cited by 141 · see citing works

Niosomes: a potential tool for novel drug delivery

Khan, R., & Irchhaiya, R. (2016) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-016-0249-9 · Cited by 140 · see citing works

Smart pH-responsive nanomedicines for disease therapy

Shinn, J., Kwon, N., Lee, S. A., & Lee, Y. (2022) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-022-00573-z · Cited by 138 · see citing works

3D printing for oral drug delivery: a new tool to customize drug delivery

Pandey, M., Choudhury, H., Fern, J. L. C., Kee, A. T. K., Kou, J., Jing, J. L. J., Her, H. C., Yong, H. S., Ming, H. C., Bhattamisra, S. K., et al. (2020) · Drug Delivery and Translational Research · doi:10.1007/s13346-020-00737-0 · Cited by 135 · see citing works

Recent advances in pharmaceutical dosage forms and devices using additive manufacturing technologies

Gioumouxouzis, C. I., Karavasili, C., & Fatouros, D. G. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.11.019 · Cited by 134 · see citing works

The Epidemiology of Helicobacter pylori

Mitchell, H. M. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-60013-5_2 · Cited by 130 · see citing works

Nanomedicines: Redefining traditional medicine

Lu, W., Yao, J., Zhu, X. M., & Qi, Y. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.111103 · Cited by 129 · see citing works

Diagnosis and management of pertussis

Tozzi, A. E. (2005) · Canadian Medical Association Journal · doi:10.1503/cmaj.1040766 · Cited by 123 · see citing works

Traditional and syndromic surveillance of infectious diseases and pathogens

Abat, C., Chaudet, H., Rolain, J., Colson, P., & Raoult, D. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.04.021 · Cited by 121 · see citing works

Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia

Bielicki, J. A., Stöhr, W., Barratt, S., Dunn, D. T., Naufal, N., Roland, D., Sturgeon, K., Finn, A. H. R., Ruiz, J. P. R., Malhotra‐Kumar, S., et al. (2021) · JAMA · doi:10.1001/jama.2021.17843 · Cited by 119 · see citing works

Determination of formulation factors that affect oral medicines acceptability in a domiciliary paediatric population

Venables, R. H., Batchelor, H. K., Hodson, J. A., Stirling, H., & Marriott, J. F. (2015) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2015.01.023 · Cited by 117 · see citing works

Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns

Assefa, M. (2022) · Pneumonia · doi:10.1186/s41479-022-00096-z · Cited by 115 · see citing works

Delivery devices for the administration of paediatric formulations: Overview of current practice, challenges and recent developments

Walsh, J., Bickmann, D., Breitkreutz, J., & Chariot-Goulet, M. (2011) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2011.05.048 · Cited by 114 · see citing works

Paediatric specific dosage forms: Patient and formulation considerations

Khan, D., Kirby, D. J., Bryson, S., Shah, M., & Mohammed, A. R. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.121501 · Cited by 112 · see citing works

Physiologically Important Metal Nanoparticles and Their Toxicity

Sengupta, J., Ghosh, S., Datta, P., Gomes, A., & Gomes, A. (2014) · Journal of Nanoscience and Nanotechnology · doi:10.1166/jnn.2014.9078 · Cited by 111 · see citing works

A new intragastric delivery system for the treatment of Helicobacter pylori associated gastric ulcer: in vitro evaluation

Yang, L. (1999) · Journal of Controlled Release · doi:10.1016/s0168-3659(98)00066-2 · Cited by 107 · see citing works

Giardiasis outbreaks in the United States, 1971–2011

Adam, E. A., Yoder, J. S., Gould, L. H., Hlavsa, M. C., & Gargano, J. W. (2016) · Epidemiology and Infection · doi:10.1017/s0950268815003040 · Cited by 106 · see citing works

Community-Acquired Pneumonia in Children: Myths and Facts

Yun, K. W., Wallihan, R. G., Juergensen, A., Mejías, A., & Ramilo, O. (2019) · American Journal of Perinatology · doi:10.1055/s-0039-1691801 · Cited by 106 · see citing works

WHO Expert Committee on specifications for pharmaceutical preparations

(2008) · Revista do Instituto de Medicina Tropical de São Paulo · doi:10.1590/s0036-46652008000300013 · Cited by 106 · see citing works

Recommendations for Prevention and Control of Influenza in Children, 2012–2013

Brady, M. T., Byington, C. L., Davies, H. D., Edwards, K. M., Glodé, M. P., Jackson, M. A., KEYSERLING, H. L., Maldonado, Y., Murray, D. L., Orenstein, W. A., et al. (2012) · PEDIATRICS · doi:10.1542/peds.2012-2308 · Cited by 103 · see citing works

HIV treatment and prevention 2019

Phanuphak, N., & Gulick, R. M. (2019) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000588 · Cited by 101 · see citing works

Tuberculosis Infection in Children and Adolescents: Testing and Treatment

Nolt, D. L., & Starke, J. R. (2021) · PEDIATRICS · doi:10.1542/peds.2021-054663 · Cited by 99 · see citing works

Anti-Helicobacter pylori, cytotoxicity and catalytic activity of biosynthesized gold nanoparticles: Multifaceted application

Gopinath, V., Priyadarshini, S., MubarakAli, D., Loke, M. F., Thajuddin, N., Alharbi, N. S. H. A., Yadavalli, T., Alagiri, M., & Vadivelu, J. (2016) · Arabian Journal of Chemistry · doi:10.1016/j.arabjc.2016.02.005 · Cited by 99 · see citing works

Giardiasis: Characteristics, Pathogenesis and New Insights About Treatment

Vivancos, V., González‐Álvarez, I., Bermejo, M., & González‐Álvarez, M. (2018) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026618666181002095314 · Cited by 99 · see citing works

Review: Epidemiology of Helicobacter pylori

Mežmale, L., Coelho, L. G. V., Bordin, D. S., & Leja, M. (2020) · Helicobacter · doi:10.1111/hel.12734 · Cited by 99 · see citing works

Parental knowledge, attitudes and antibiotic use for acute upper respiratory tract infection in children attending a primary healthcare clinic in Malaysia.

Chan, G., & Tang, S. (2006) · PubMed · Cited by 97 · see citing works

Efficacy of short-term treatment of pertussis with clarithromycin and azithromycin

Aoyama, T., Sunakawa, K., Iwata, S., Takeuchi, Y., & Fujii, R. (1996) · The Journal of Pediatrics · doi:10.1016/s0022-3476(96)70163-4 · Cited by 96 · see citing works

Oral drug delivery strategies for development of poorly water soluble drugs in paediatric patient population

Salunke, S., O’Brien, F., Tan, D. C. T., Harris, D., Math, M.-C., Ariën, T., Klein, S., & Timpe, C. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114507 · Cited by 93 · see citing works

Pharmaceutical care recommendations for antiviral treatments in children with coronavirus disease 2019

Wang, Y., & Zhu, L. (2020) · World Journal of Pediatrics · doi:10.1007/s12519-020-00353-5 · Cited by 92 · see citing works

Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulation

Gupta, A., Shetty, S., Mutalik, S., Hariharapura, R. C., Nandakumar, K., Mathew, E. M., Jha, A., Mishra, B., Rajpurohit, S., Ravi, G., et al. (2023) · Heliyon · doi:10.1016/j.heliyon.2023.e20406 · Cited by 92 · see citing works

Communicable Diseases: Achievements and Challenges for Public Health

Schlipköter, U., & Flahault, A. (2010) · Public health reviews · doi:10.1007/bf03391594 · Cited by 89 · see citing works

Safety and effectiveness of neuraminidase inhibitors for influenza treatment, prophylaxis, and outbreak control: a systematic review of systematic reviews and/or meta-analyses

Doll, M. K., Winters, N., Boikos, C., Kraicer‐Melamed, H., Gore, G. C., & Quach, C. (2017) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkx271 · Cited by 87 · see citing works

Safe and effective pharmacotherapy in infants and preschool children: importance of formulation aspects

van Riet‐Nales, D. A., Schobben, A. F. A. M., Vromans, H., Egberts, T. C. G., & Rademaker, C. M. A. (2016) · Archives of Disease in Childhood · doi:10.1136/archdischild-2015-308227 · Cited by 87 · see citing works

Seven Days of Erythromycin Estolate Is as Effective as Fourteen Days for the Treatment of Bordetella pertussis Infections

Halperin, S. A., Bortolussi, R. A., Langley, J. M., Miller, B., & Eastwood, B. J. (1997) · PEDIATRICS · doi:10.1542/peds.100.1.65 · Cited by 86 · see citing works

Oral recombinant Lactobacillus vaccine targeting the intestinal microfold cells and dendritic cells for delivering the core neutralizing epitope of porcine epidemic diarrhea virus

Ma, S., Wang, L., Huang, X., Wang, X., Chen, S., Shi, W., Qiao, X., Jiang, Y., Tang, L., Xu, Y., et al. (2018) · Microbial Cell Factories · doi:10.1186/s12934-018-0861-7 · Cited by 86 · see citing works

[Chinese guidelines for diagnosis and treatment of HIV/AIDS (2021 edition)].

(2021) · PubMed · doi:10.3760/cma.j.cn112138-20211006-00676 · Cited by 84 · see citing works

Innovations in Chewable Formulations: The Novelty and Applications of 3D Printing in Drug Product Design

Rodríguez‐Pombo, L., Awad, A., Basit, A. W., Alvarez‐Lorenzo, C., & Goyanes, Á. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14081732 · Cited by 83 · see citing works

Functionalized materials for multistage platforms in the oral delivery of biopharmaceuticals

Araújo, F., das Neves, J., Martins, J. P., Granja, P. L., Santos, H. A., & Sarmento, B. F. C. C. (2017) · Progress in Materials Science · doi:10.1016/j.pmatsci.2017.05.001 · Cited by 80 · see citing works

A systematic review on the treatment of giardiasis

Zaat, J. O. M., Mank, T. G., & Assendelft, W. J. (1997) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.1997.d01-132.x · Cited by 78 · see citing works

Nanotechnology in Targeted Drug Delivery

Stefano, A. D. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098194 · Cited by 74 · see citing works

Giardiasis treatment: an update with a focus on refractory disease

Mørch, K., & Hanevik, K. (2020) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000668 · Cited by 73 · see citing works

Clostridioides difficile Infection in Children: Recent Updates on Epidemiology, Diagnosis, Therapy

Shirley, D.-A. T., Tornel, W., Warren, C. A., & Moonah, S. N. (2023) · PEDIATRICS · doi:10.1542/peds.2023-062307 · Cited by 72 · see citing works

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel

Gandhi, R. T., Bedimo, R., Hoy, J., Landovitz, R. J., Smith, D. M., Eaton, E. F., Lehmann, C., Springer, S. A., Sax, P. E., Thompson, M., et al. (2023) · Zurich Open Repository and Archive (University of Zurich) · doi:10.5167/uzh-253001 · Cited by 66 · see citing works

Diagnosis and Management of Group a Streptococcal Pharyngitis in the United States, 2011–2015

Luo, R. F., Sickler, J. J., Vahidnia, F., Lee, Y.-C., Frogner, B. K., & Thompson, M. (2019) · BMC Infectious Diseases · doi:10.1186/s12879-019-3835-4 · Cited by 65 · see citing works

FAST DISSOLVING TABLETS: A REVIEW

Masih, A., Kumar, A., Singh, S., & Tiwari, A. K. (2017) · International Journal of Current Pharmaceutical Research · doi:10.22159/ijcpr.2017v9i2.17382 · Cited by 65 · see citing works

Electrospun Orodispersible Films of Isoniazid for Pediatric Tuberculosis Treatment

Chachlioutaki, K., Tzimtzimis, E. K., Tzetzis, D., Chang, M., Ahmad, Z., Karavasili, C., & Fatouros, D. G. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12050470 · Cited by 65 · see citing works

Features and Facts of a Gastroretentive Drug Delivery System-A Review

Vinchurkar, K., Sainy, J., KHAN, M. A., Mane, S., Mishra, D. K., & DIXIT, P. (2022) · Turkish Journal of Pharmaceutical Sciences · doi:10.4274/tjps.galenos.2021.44959 · Cited by 64 · see citing works

Antiviral therapy of influenza

Englund, J. A. (2002) · Seminars in Pediatric Infectious Diseases · doi:10.1053/spid.2002.122999 · Cited by 62 · see citing works

Novel therapies and preventative strategies for primary and recurrent Clostridium difficile infections

Dieterle, M. G., Rao, K. K., & Young, V. B. (2018) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.13958 · Cited by 62 · see citing works

Lymphocyte subsets in human immunodeficiency virus type 1-infected and uninfected children in Nairobi

Embreé, J., Bwayo, J. J., Nagelkerke, N. J. D., Njenga, S., Nyange, P. M., Ndinya‐Achola, J. O., Pamba, H. O., & Plummer, F. A. (2001) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200104000-00006 · Cited by 62 · see citing works

Anti-GiardiaDrug Discovery: Current Status and Gut Feelings

Riches, A. G., Hart, C. J. S., Trenholme, K. R., & Skinner‐Adams, T. S. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00910 · Cited by 61 · see citing works

Group A streptococcal (GAS) infections amongst children in Europe: Taming the rising tide

Jain, N., Lansiaux, É., & Reinis, A. (2022) · New Microbes and New Infections · doi:10.1016/j.nmni.2022.101071 · Cited by 61 · see citing works

Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel

Smith, D. M., Volberding, P. A., Jacobsen, D. M., Saag, M. S., Sax, P. E., del Rı́o, C., Eron, J. J., Landovitz, R. J., Thompson, M., Hoy, J., et al. (2020) · eScholarship (California Digital Library) · doi:10.17615/k858-n421 · Cited by 60 · see citing works

Recent developments of nanotherapeutics for targeted and long-acting, combination HIV chemotherapy

Gao, Y., Kraft, J. C., Yu, D., & Ho, R. J. Y. (2018) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2018.04.014 · Cited by 59 · see citing works

Clostridium Difficile Infection in Children

Borali, E., & Giacomo, C. D. (2016) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0000000000001264 · Cited by 55 · see citing works

Tuberculosis in Children

Holmberg, P. J., Temesgen, Z., & Banerjee, R. (2019) · Pediatrics in Review · doi:10.1542/pir.2018-0093 · Cited by 55 · see citing works

Helicobacter pylori Antibiotic Resistance: Molecular Basis and Diagnostic Methods

Medakina, I., Tsapkova, L., Polyakova, V., Nikolaev, S., Yanova, T., Дехнич, Н. Н., Khatkov, I. E., Bordin, D. S., & Бодунова, Н. А. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119433 · Cited by 53 · see citing works

Efficacy of 5-Nitroimidazoles for the Treatment of Giardiasis: A Systematic Review of Randomized Controlled Trials

Pasupuleti, V., Escobedo, A. A., Deshpande, A., Thota, P., Roman, Y. M., & Hernández, A. V. (2014) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0002733 · Cited by 52 · see citing works

Pediatric Tuberculosis Management: A Global Challenge or Breakthrough?

Maphalle, L. N. F., Michniak‐Kohn, B. B., Ogunrombi, M. O., & Adeleke, O. A. (2022) · Children · doi:10.3390/children9081120 · Cited by 51 · see citing works

Historical development of drug delivery systems: From conventional macroscale to controlled, targeted, and responsive nanoscale systems

Abu-Thabit, N. Y., & Hamdy, A. S. (2018) · Elsevier eBooks · doi:10.1016/b978-0-08-101997-9.00001-1 · Cited by 50 · see citing works

Drug Delivery Innovations to Address Global Health Challenges for Pediatric and Geriatric Populations (Through Improvements in Patient Compliance)

Boateng, J. S. (2017) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2017.07.009 · Cited by 49 · see citing works

Neonatal and pediatric oral drug delivery: Hopes and hurdles

Mfoafo, K. A., Omidian, M., Bertol, C. D., Omidi, Y., & Omidian, H. (2021) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2021.120296 · Cited by 48 · see citing works

Antibiotic Treatment Duration for Community-Acquired Pneumonia in Outpatient Children in High-Income Countries—A Systematic Review and Meta-Analysis

Kuitunen, I., Jääskeläinen, J., Korppi, M. O., & Renko, M. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac374 · Cited by 48 · see citing works

Novel formulation and drug delivery strategies for the treatment of pediatric poverty-related diseases

Sosnik, A., Seremeta, K. P., Imperiale, J. C., & Chiappetta, D. A. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.655268 · Cited by 47 · see citing works

Floating-bioadhesive gastroretentiveCaesalpinia pulcherrima-based beads of amoxicillin trihydrate forHelicobacter pylorieradication

Thombre, N. A., & Gide, P. (2014) · Drug Delivery · doi:10.3109/10717544.2014.916766 · Cited by 46 · see citing works

Ensuring the Involvement of Children in the Evaluation of New Tuberculosis Treatment Regimens

Burman, W. J., Cotton, M. F., Gibb, D. M., Walker, A. S., Vernon, A. A., & Donald, P. R. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050176 · Cited by 46 · see citing works

Effectiveness of pneumococcal conjugate vaccines against invasive pneumococcal disease among children under five years of age in Africa: A systematic review

Ngocho, J. S., Magoma, B., Olomi, G. A., Mahande, M. J., Msuya, S. E., de Jonge, M. I., & Mmbaga, B. T. (2019) · PLoS ONE · doi:10.1371/journal.pone.0212295 · Cited by 45 · see citing works

Mucoadhesive Drug Delivery Systems: A Review of Recent Developments

Alawdi, S. H., & Solanki, A. B. (2021) · Journal of Scientific Research in Medical and Biological Sciences · doi:10.47631/jsrmbs.v2i1.213 · Cited by 45 · see citing works

Recommendations for Prevention and Control of Influenza in Children, 2021–2022

Maldonado, Y., O’Leary, S. T., Ardura, M. I., Banerjee, R., Bryant, K. A., Campbell, J. D., Caserta, M. T., John, C. C., Gerber, J. S., Kourtis, A. P., et al. (2021) · PEDIATRICS · doi:10.1542/peds.2021-053745 · Cited by 44 · see citing works

OVERVIEW ON FLOATING DRUG DELIVERY SYSTEM

Niharika, M. G., Krishnamoorthy, K., & Akkala, M. (2018) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2018v10i6.28274 · Cited by 44 · see citing works

Seasonal influenza in children: Costs for the health system and society in Europe

Villani, L., D’Ambrosio, F., Ricciardi, R., de Waure, C., & Calabrò, G. E. (2022) · Influenza and Other Respiratory Viruses · doi:10.1111/irv.12991 · Cited by 44 · see citing works

Orodispersible Films—Current State of the Art, Limitations, Advances and Future Perspectives

Ferlak, J., Guzenda, W., & Osmałek, T. Z. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15020361 · Cited by 44 · see citing works

An Imperative Note on Novel Drug Delivery Systems

Bheemidi, V. S. (2011) · Journal of Nanomedicine & Nanotechnology · doi:10.4172/2157-7439.1000125 · Cited by 42 · see citing works

Bioadhesive or Mucoadhesive Drug Delivery System: A Potential Alternative to Conventional Therapy

Asati, S., Jain, S. V., & Choubey, A. (2019) · Journal of Drug Delivery and Therapeutics · doi:10.22270/jddt.v9i4-a.3708 · Cited by 39 · see citing works

Orally disintegrating drug carriers for paediatric pharmacotherapy

Kean, E. A., & Adeleke, O. A. (2023) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2023.106377 · Cited by 39 · see citing works

Diagnosis and treatment of extrapulmonary tuberculosis

Kim, S. (2014) · Journal of Korean Medical Association · doi:10.5124/jkma.2014.57.1.34 · Cited by 38 · see citing works

Design and development of lipid modified chitosan containing muco-adhesive self-emulsifying drug delivery systems for cefixime oral delivery

Saifullah, S., Kanwal, T., Ullah, S., Kawish, M., Habib, S. M., Ali, I., Munir, A., Imran, M. A., & Shah, M. R. (2021) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2021.105052 · Cited by 38 · see citing works

Nanoformulation strategies for the enhanced oral bioavailability of antiretroviral therapeutics.

Tatham, L. M., Rannard, S., & Owen, A. (2015) · Therapeutic delivery · doi:10.4155/tde.15.4 · Cited by 37 · see citing works

Trends in antiretroviral therapy prescription, durability and modification

Eaton, E., Tamhane, A. R., Davy-Méndez, T., Mathews, W. C., Moore, R. D., Saag, M. S., & Mugavero, M. J. (2017) · AIDS · doi:10.1097/qad.0000000000001708 · Cited by 37 · see citing works

Recommendations for Prevention and Control of Influenza in Children, 2022–2023

COMMITTEE ON INFECTIOUS DISEASES (2022) · PEDIATRICS · doi:10.1542/peds.2022-059274 · Cited by 37 · see citing works

A review and revisit of nanoparticles for antimicrobial drug delivery

Liew, K. B., Janakiraman, A. K., Ramkanth, S., Khalid, S. H., Razzaq, F. A., Ming, L. C., Khan, M. A. S., Kalusalingam, A., & Ng, P. W. (2022) · Journal of Medicine and Life · doi:10.25122/jml-2021-0097 · Cited by 36 · see citing works

Association Between Viewing Health Care Price Information and Choice of Health Care Facility

Sinaiko, A. D., Joynt, K. E., & Rosenthal, M. B. (2016) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2016.6622 · Cited by 36 · see citing works

Novel Nanotechnology-Based Approaches for Targeting HIV Reservoirs

Abadi, L. F., Damiri, F., Zehravi, M., Joshi, R., Pai, R. V., Berrada, M., Massoud, E. E. S., Rahman, M. H., Rojekar, S. V., & Cavalu, S. D. (2022) · Polymers · doi:10.3390/polym14153090 · Cited by 35 · see citing works

Current research toward optimizing dosing of first-line antituberculosis treatment

McIlleron, H., & Chirehwa, M. (2018) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2019.1555031 · Cited by 35 · see citing works

Recommendations for Prevention and Control of Influenza in Children, 2023–2024

O’Leary, S. T., Campbell, J. D., Ardura, M. I., Banerjee, R., Bryant, K. A., Caserta, M. T., Frenck, R. W., Gerber, J. S., John, C. C., Kourtis, A. P., et al. (2023) · PEDIATRICS · doi:10.1542/peds.2023-063772 · Cited by 34 · see citing works

Re-evaluation of antibiotic treatment of streptococcal pharyngitis

Baltimore, R. S. (2010) · Current Opinion in Pediatrics · doi:10.1097/mop.0b013e32833502e7 · Cited by 33 · see citing works

Morphology and Size of Bacterial Colonies Control Anoxic Microenvironment Formation in Porous Media

Ceriotti, G., Borisov, S. M., Berg, J. S., & de Anna, P. (2022) · Environmental Science & Technology · doi:10.1021/acs.est.2c05842 · Cited by 33 · see citing works

Systemic administration of RANKL overcomes the bottleneck of oral vaccine delivery through microfold cells in ileum

Maharjan, S., Singh, B., Jiang, T., Yoon, S.-Y., Li, H.-S., Kim, G., Gu, M. J., Kim, S. J., Park, O.-J., Han, S. H., et al. (2016) · Biomaterials · doi:10.1016/j.biomaterials.2016.01.043 · Cited by 32 · see citing works

Management and control of communicable diseases in schools and other child care settings: systematic review on the incubation period and period of infectiousness

The ECDC expert panel working group, Czumbel, I., Quinten, C., Lopalco, P. L., & Semenza, J. C. (2018) · BMC Infectious Diseases · doi:10.1186/s12879-018-3095-8 · Cited by 32 · see citing works

Optimizing Pediatric Dosing Recommendations and Treatment Management of Antiretroviral Drugs Using Therapeutic Drug Monitoring Data in Children Living With HIV

Waalewijn, H., Turkova, A., Rakhmanina, N. Y., Cressey, T. R., Penazzato, M., Colbers, A. P. H., Burger, D. M., & on behalf of the Pediatric Antiretroviral Working Group (PAWG) (2019) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000000637 · Cited by 32 · see citing works

Floating modular drug delivery systems with buoyancy independent of release mechanisms to sustain amoxicillin and clarithromycin intra-gastric concentrations

Rossi, A., Conti, C., Colombo, G., Castrati, L., Scarpignato, C., Barata, P., Sandri, G., Caramella, C. M., Bettini, R., Buttini, F., et al. (2015) · Drug Development and Industrial Pharmacy · doi:10.3109/03639045.2015.1054397 · Cited by 32 · see citing works

Pharmacokinetics of First-Line Drugs in Children With Tuberculosis, Using World Health Organization–Recommended Weight Band Doses and Formulations

Chabala, C., Turkova, A., Hesseling, A. C., Zimba, K. M., van der Zalm, M. M., Kapasa, M., Palmer, M., Chirehwa, M., Wiesner, L., Wobudeya, E., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab725 · Cited by 32 · see citing works

Opportunities for milk and milk-related systems as ‘new’ low-cost excipient drug delivery materials

Salim, M., Eason, T., & Boyd, B. J. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114139 · Cited by 32 · see citing works

Probiotics and autoprobiotics for treatment of Helicobacter pylori infection

Baryshnikova, N. V., Ilina, A., Ермоленко, Е. И., Uspenskiy, Y. P., & Suvorov, A. N. (2023) · World Journal of Clinical Cases · doi:10.12998/wjcc.v11.i20.4740 · Cited by 32 · see citing works

Silica-Coated Magnetic Nanoparticles for Vancomycin Conjugation

Abdelaziz, M. M., Hefnawy, A., Anter, A., Abdellatif, M. M., Khalil, M. A. F., & Khalil, I. A. H. (2022) · ACS Omega · doi:10.1021/acsomega.2c03226 · Cited by 31 · see citing works

Age-appropriate solid oral formulations for pediatric applications with a focus on multiparticulates and minitablets: Summary of September 2019 EuPFI workshop

Harris, D., Hermans, E., Klein, S., Wagner-Hattler, L., & Walsh, J. (2020) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2020.06.012 · Cited by 31 · see citing works

The treatment of streptococcal tonsillitis/pharyngitis in young children

Norton, L. E., & Myers, A. (2021) · World Journal of Otorhinolaryngology - Head and Neck Surgery · doi:10.1016/j.wjorl.2021.05.005 · Cited by 31 · see citing works

Diagnosis and Treatment of Streptococcal Pharyngitis

Tison, D. L. (1985) · JAMA · doi:10.1001/jama.1985.03360070045010 · Cited by 30 · see citing works

Ga(III) Nanoparticles Inhibit Growth of both Mycobacterium tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages

Choi, S.-R., Britigan, B., & Narayanasamy, P. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02505-16 · Cited by 29 · see citing works

Pyrazinamide serum levels in childhood tuberculosis.

Thee, S. A., Detjen, A., Wahn, U., & Magdorf, K. (2008) · PubMed · Cited by 29 · see citing works

Giardiasis surveillance -- United States, 2011-2012.

Painter, J. E., Gargano, J. W., Collier, S. A., & Yoder, J. S. (2015) · PubMed · Cited by 29 · see citing works

Tuberculosis treatment in children: The changing landscape

Huynh, J., Thwaites, G. E., Marais, B. J., & Schaaf, H. S. (2020) · Paediatric Respiratory Reviews · doi:10.1016/j.prrv.2020.02.002 · Cited by 29 · see citing works

Orodispersible tablets for pediatric drug delivery: current challenges and recent advances

Wiedey, R., Kokott, M., & Breitkreutz, J. (2021) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2021.2011856 · Cited by 29 · see citing works

Mechanisms and impact of antimicrobial resistance in Clostridioides difficile

Dureja, C., Olaitan, A. O., & Hurdle, J. G. (2022) · Current Opinion in Microbiology · doi:10.1016/j.mib.2022.01.004 · Cited by 28 · see citing works

Giardiasis Diagnosis and Treatment Practices Among Commercially Insured Persons in the United States

Beer, K. D., Collier, S. A., Du, F., & Gargano, J. W. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix138 · Cited by 28 · see citing works

Efficacy, safety and acceptability of a new chewable formulation versus the solid tablet of mebendazole against hookworm infections in children: An open-label, randomized controlled trial

Palmeirim, M. S., Bosch, F., Ame, S. M., Ali, S. M., Hattendorf, J., & Keiser, J. (2020) · EClinicalMedicine · doi:10.1016/j.eclinm.2020.100556 · Cited by 28 · see citing works

National Communicable Disease Surveillance System: A review on Information and Organizational Structures in Developed Countries

Bagherian, H., Farahbaksh, M., Rabiei, R., Moghaddasi, H., & Asadi, F. (2017) · Acta Informatica Medica · doi:10.5455/aim.2017.25.271-276 · Cited by 28 · see citing works

Paediatric oral formulations: Why don't our kids have the medicines they need?

Juárez‐Hernández, J. E., & Carleton, B. (2022) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.15456 · Cited by 27 · see citing works

The Gut-Wrenching Effects of Cryptosporidiosis and Giardiasis in Children

Prabakaran, M., Weible, L. J., Champlain, J., Jiang, R., Biondi, K., Weil, A. A., A, W. C. V. V., & Ojo, K. K. (2023) · Microorganisms · doi:10.3390/microorganisms11092323 · Cited by 27 · see citing works

Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial

Tsalik, E. L., Rouphael, N., Sadikot, R. T., Rodriguez‐Barradas, M. C., McClain, M. T., Wilkins, D. M., Woods, C. W., Swamy, G. K., Walter, E. B., Sahly, H. M. E., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00735-6 · Cited by 26 · see citing works

A review on taste masked multiparticulate dosage forms for paediatric

AL-Japairai, K. A. S., Almurisi, S. H., Doolaanea, A. A., Mahmood, S., Alheibshy, F., Alobaida, A., Abdul-Halim, N., & Chatterjee, B. (2022) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2022.122571 · Cited by 26 · see citing works

A Comparison of Antibiotic Use in Children Between Canada and Denmark

Marra, F., Monnet, D. L., Patrick, D. M., Chong, M., Brandt, C., Winters, M., Kaltoft, M. S., Tyrrell, G. J., Lovgren, M., & Bowie, W. (2007) · Annals of Pharmacotherapy · doi:10.1345/aph.1h293 · Cited by 26 · see citing works

Bioavailability of two licensed paediatric rifampicin suspensions: implications for quality control programmes

McIlleron, H., Hundt, H. K. L., Smythe, W., Bekker, A., Winckler, J., van der Laan, L., Smith, P. J., Zar, H. J., Hesseling, A. C., Maartens, G., et al. (2016) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.15.0833 · Cited by 26 · see citing works

An updated review on application of 3D printing in fabricating pharmaceutical dosage forms

Parhi, R., & Jena, G. K. (2021) · Drug Delivery and Translational Research · doi:10.1007/s13346-021-01074-6 · Cited by 26 · see citing works

Isoniazid-loaded orodispersible strips: Methodical design, optimization and in vitro-in silico characterization

Adeleke, O. A., Tsai, P.-C., Karry, K. M., Monama, N. O., & Michniak‐Kohn, B. B. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.06.004 · Cited by 26 · see citing works

Alternative dosing guidelines to improve outcomes in childhood tuberculosis: a mathematical modelling study

Radtke, K. K., Dooley, K. E., Dodd, P. J., Garcia‐Prats, A. J., McKenna, L., Hesseling, A. C., & Savić, R. M. (2019) · The Lancet Child & Adolescent Health · doi:10.1016/s2352-4642(19)30196-8 · Cited by 26 · see citing works

Development and characterization of orodispersible film containing cefixime trihydrate

Khan, Q.-U.-A., Siddique, M. I., Rasool, F., Naeem, M., Usman, M. H., & Zaman, M. (2020) · Drug Development and Industrial Pharmacy · doi:10.1080/03639045.2020.1843477 · Cited by 26 · see citing works

Diagnosis and treatment ofHelicobacter pyloriinfections in children and elderly populations

Peng, C., Hu, Y., Ge, Z., Zou, Q., & Lyu, N. (2019) · Chronic Diseases and Translational Medicine · doi:10.1016/j.cdtm.2019.12.003 · Cited by 25 · see citing works

Orodispersible Tablets: A Review

Vishali, T., & Narayanasamy, D. (2020) · Research Journal of Pharmacy and Technology · doi:10.5958/0974-360x.2020.00449.7 · Cited by 25 · see citing works

Optimal Design, Characterization and Preliminary Safety Evaluation of an Edible Orodispersible Formulation for Pediatric Tuberculosis Pharmacotherapy

Matawo, N., Adeleke, O. A., & Wesley‐Smith, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165714 · Cited by 25 · see citing works

Recommendations for Prevention and Control of Influenza in Children, 2022–2023

COMMITTEE ON INFECTIOUS DISEASES (2022) · PEDIATRICS · doi:10.1542/peds.2022-059275 · Cited by 25 · see citing works

Single-dose therapy for giardiasis in school-age children.

Pengsaa, K., Limkittikul, K., Pojjaroen‐Anant, C., Lapphra, K., Sirivichayakul, C., Wisetsing, P., Nantha-aree, P., & Chanthavanich, P. (2002) · PubMed · Cited by 24 · see citing works

Tuberculosis in children, adolescents, and women

Marais, B. J., Amanullah, F., Gupta, A., Becerra, M. C., Snow, K. J., Ngadaya, E. S., Sharma, M., Hesseling, A. C., Chakaya, M., & Zumla, A. I. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30077-1 · Cited by 24 · see citing works

Treatment of Pertussis—2017

Cherry, J. D. (2017) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/pix044 · Cited by 23 · see citing works

The osmotic stress response of split influenza vaccine particles in an acidic environment

Choi, H., Kim, M., Kang, S., & Montemagno, C. D. (2013) · Archives of Pharmacal Research · doi:10.1007/s12272-013-0257-5 · Cited by 22 · see citing works

Optimal First-Line Treatment for Helicobacter pylori Infection: Recent Strategies

Lee, J. Y., & Park, K. S. (2016) · Gastroenterology Research and Practice · doi:10.1155/2016/9086581 · Cited by 22 · see citing works

3D-printed chewable gummy tablets: A new tool for oral amoxicillin administration in paediatric population

Imbriano, A., Fratini, C., Bondi, G., D’Abbrunzo, I., Bertoni, S., Tiboni, M., Abruzzo, A., Hasa, D., Pagano, C., & Casettari, L. (2025) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2025.125645 · Cited by 13 · see citing works

Precision Pediatric Cancer Nanomedicine: Advancing Personalized Nano Therapies to Reduce Non-Communicable Diseases Through AI-Driven 3D-Printed Drugs

Choudhary, N., Kumar, D., Jyoti, T. P., Prajapati, B. G., Kchaou, M., Webster, T. J., & Faiyazuddin, M. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s575214 · Cited by 5 · see citing works

DEVELOPMENT AND VALIDATION OF A GRADIENT PROGRAM RP-HPLC METHOD FOR ESTIMATION OF MULTIPLE ACTIVE PHARMACEUTICAL INGREDIENTS IN AN ORAL SUSPENSION TASTE MASKED WITH AN ION EXCHANGE RESIN

PANDIT, R. K., & PANDEY, V. (2025) · International Journal of Applied Pharmaceutics · doi:10.22159/ijap.2025v17i4.53547 · Cited by 5 · see citing works

Synthesis and Antitumor Activity of New Metronidazole‐Linked Thiophene or Pyrazole Analogues

Jabar, Y., Alinezhad, H., Tajbakhsh, M., & Gaffer, H. E. (2025) · Journal of Heterocyclic Chemistry · doi:10.1002/jhet.70002 · Cited by 3 · see citing works

Zinc Fortification and Supplementation to Reduce Diarrhea in Children: A Literature Review

Iqbal, S., Malik, Z. I., Al-Dabbas, M. M., Akhtar, I., & Hussein, A. (2025) · Diseases · doi:10.3390/diseases13110380 · Cited by 3 · see citing works

Harnessing Stem Cells for Pediatric Respiratory Diseases: Potential and Clinical Translation

Alizadeh, F., & Yasrebinia, S. (2025) · Cell Biology International · doi:10.1002/cbin.70042 · Cited by 3 · see citing works

Pioneering era in paediatric tuberculosis: Utilization of 3D printing technology

Singh, S. K., Kumar, M., Choudhary, D., Kumar, D., Dikshant, Zambad, S., Chopra, S., Bansal, M., & Bhatia, A. (2025) · Annals of 3D Printed Medicine · doi:10.1016/j.stlm.2025.100214 · Cited by 2 · see citing works

Antimicrobial Activity of Azithromycin versus Ciprofloxacin in the Treatment of Uncomplicated Enteric Fever in Children and Adolescents: Preclinical Trial

Irfan, Z., Bijarani, A. N., Pervaiz, Y. M., Perveen, F., Shaikh, S. P., & Arif, H. (2024) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v5i12.2215 · Cited by 1 · see citing works

Optimization of Antiviral Therapies among Pediatrics: Confronting Remedying Unique Challenges

Peeriga, R., Manubolu, K., Venkateshan, N., Katta, P. K., Jaafar, N. I., & Shaik, N. M. (2025) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3157 · Cited by 1 · see citing works

Recent Advances in Pediatric Infectious Diseases: A Review of Diagnostic and Therapeutic Strategies

Krishna Vamshy, J., Varshini, M., Rathore, N., Patil, R., Sinha, J., & Bhattacharjee, A. (2025) · Cureus · doi:10.7759/cureus.94523 · Cited by 1 · see citing works

Osteomyelitis in HIV pathogenesis, challenges, and therapeutic strategies

Obeagu, E. I., & Goryacheva, O. G. (2025) · Annals of Medicine and Surgery · doi:10.1097/ms9.0000000000004326 · Cited by 1 · see citing works

Polydopamine-Based Biomaterials in Oral Medicine: Applications, Mechanisms, and Translational Challenges

Yang, Z., Song, W., Lv, L., Zhai, S., Liu, Y., Cui, H., Li, X., Gao, F., & Chu, S. (2026) · International Journal of Nanomedicine · doi:10.2147/ijn.s611922

Clinical Factors Associated With Patterns of Medication Errors Among Pediatric Hospitalized Patients in Northwest Ethiopia: A Multicenter Prospective Observational Study

Moges, T. A., Dagnew, F. N., Tarekegn, G. Y., Wondm, S. A., Zewdu, W. S., Anberbr, S. S., Nigussie, H., & Dagnew, S. B. (2026) · BioMed Research International · doi:10.1155/bmri/8893135

Formulation and Evaluation of Anti-Inflammatory Chewable Gummies on Asthenopia Syndrome

Gandhi, B., Bhagwat, A., Mahale, N., Atkari, P., Shingote, R., & Bhabad, S. (2026) · Research Journal of Pharmacy and Technology · doi:10.52711/0974-360x.2026.00454

Engineering Paediatric Formulations: A Systematic Review of Process Systems Methods, Sectoral Gaps, and the PPES FrameworkPreprint

Adu, J., & Forkuo, G. O. (2026) · Research Square · doi:10.21203/rs.3.rs-10249098/v1

Nanomedicines for Efficient Diagnosis and Treatment of Pediatric Respiratory Diseases: Prospects and Challenges

Shi, Y., Ma, H., Han, W., & Li, D. (2026) · IET Nanobiotechnology · doi:10.1049/nbt2/2692282

Trends and innovations in pediatric drug formulation

Modafer, A. A., & Hershan, Y. (2019) · International Journal of Pharmacy and Pharmaceutical Science · doi:10.33545/26647222.2019.v1.i2a.101 · Cited by 1 · see citing works

Pediatric orodispersible nanoparticle delivery: recent innovations and practical challenges

Shrivastab, R. S., Tiwari, R. K., & Verma, S. K. (2026) · Bulletin of the National Research Centre/Bulletin of the National Research Center · doi:10.1186/s42269-026-01505-9

Novel approaches in Paediatric Drug Delivery System

Dey, P., Bairagi, S., & Mondal, S. K. (2024) · International Journal of Pharmaceutical Sciences and Drug Research · doi:10.25004/ijpsdr.2024.160515

Formulation Strategies for Pediatric Drug Delivery: Challenges and Advances in Targeted Therapy

Kumar, A. B., Bajwa, M., Upadhyay, K. D., Sundari, S., Sarma, M. P., & Rajpal, M. (2026) · International Journal of Drug Delivery Technology · doi:10.25258/ijddt.16.47s.5

Recent Advancement: 3D-Printed Orodispersible Film as Pharmaceutical Dosage Forms for Paediatric Patients

Bhavesh Machhi*, A. C. (2025) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.14673091